Molecular basis of Alzheimer's disease

Cellular and Molecular Life Sciences

Volumn 57, Issue 5, 2000, Pages 705-715

  Drouet, B ^a   Pincon Raymond M ^a   Chambaz, J ^a   Pillot, T ^a  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

Alzheimer's disease; Amyloid peptide; Apolipoprotein E; Cholesterol homeostasis; Presenilin

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; MEMBRANE PHOSPHOLIPID; PRESENILIN 1; PRESENILIN 2;

ALZHEIMER DISEASE; CELL DEATH; CYTOSKELETON; GLIA CELL; HUMAN; MOLECULAR BIOLOGY; NERVE CELL; NEUROPATHOLOGY; REVIEW; SYNAPSE VESICLE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; APOLIPOPROTEINS E; APOPTOSIS; CELL MEMBRANE; CHOLESTEROL; HUMANS; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; NECROSIS; NEUROGLIA; PRESENILIN-1; PRESENILIN-2; TAU PROTEINS;

EID: 0034042881     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050035     Document Type: Review

References (91)

1. 1 Wisniewski T., Ghiso J. and Fangione B. (1997) Biology of Aβ in Alzheimer's disease. Neurobiol. Dis. 4: 313-328
2. 2 Rogaev E. I., Sherrington R., Rogaeva E. A., Levesque G., Ikeda M., Liang Y. et al. (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome I related to the Alzheimer's disease type 3 gene. Nature 376: 775-778
3. 3 Sherrington R., Rogaev E. I., Liang Y., Rogaeva E. A., Levesque G., Ikeda M. et al. (1995) Cloning of a gene bearing missense mutations in early-onset familiar Alzheimer's disease. Nature 375: 754-759
4. 4 Marx J. (1998) New gene tied to common form of Alzheimer's. Science 281: 508-509
5. 5 Blacker D., Wilcox M., Laird N. M., Rodes L., Horvath S. M., Go R. C. P. et al. (1998) Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat. Genet. 19: 357-360
6. 6 Kalaria R. J. (1993) The immunopathology of Alzheimer's disease and some related disorders. Brain Pathol. 3: 333-347
7. 7 Billlingsley M. L. and Kincaid R. (1997) Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem. J. 323: 577-591
8. 8 Imahori K., Hoshi M., Ishiguro K., Sato K., Takahashi M., Shiurba R. et al. (1998) Possible role of tau protein kinases in pathogenesis of Alzheimer's disease. Neurobiol. Aging 19: S93-S98
9. 9 Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N. et al. (1996) Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2: 864-868
10. 10 Bronfman F. C., Garrido J., Alvarez A., Morgan C. and Inestrosa N. C. (1996) Laminin inhibits amyloid-β-peptide fibrillation. Neurosci. Lett. 218: 201-203
11. 11 Castillo G. M., Ngo C., Cummings J., Wight T. N. and Snow A. D. (1997) Perlecan binds to the β-amyloid proteins (Aβ) of Alzheimer's disease, accelerates Aβ fibril formation, and maintains Aβ fibril stability. J. Neurochem. 69: 2452-2465
12. 12 Alvarez A., Alarcon R., Opazo C., Campos E., Munoz F. J., Calderon F. et al. (1998) Stable complexes involving acetyl-cholineterase and amyloid-β peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. J. Neurosci. 18: 3213-3223
13. 13 Du Y., Bales K. R., Dodel R., Liu X., Glinn M. A., Horn J. et al. (1998) α2-Macroglobulin attenuates β-amyloid peptide 1 - 40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons. J. Neurochem. 70: 1182-1188
14. 14 Shin R.-W., Ogino K., Kondo A., Saido T. C., Trojanowski J. W., Kitamoto T. et al. (1997) Amyloid β-protein (Aβ) 1 - 40 but not AβI 42 contributes to the experimental formation of Alzheimer disease amyloid fibrils in rat brain. J. Neurosci. 17: 8187-8193
15. 15 Yaar M., Zhai S., Pilch P. F., Doyle S. M., Eisenhauer P. B., Fine R. E. et al. (1997) Binding of β-amyloid to the p75 neurotrophin receptor induces apoptosis. Neurobiol. Dis. 100: 2333-2340
16. 16 Van S., Chen X., Zhu H., Roher A., Slattery T., Zhao L. et al. (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382: 685-691
17. 17 El Khoury J., Hickman S., Thomas C., Cao L., Silverstein S. and Loike J. (1996) Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature 382: 716-719
18. 18 Liu Y., Dargusch R. and Schubert D. (1997) Beta amyloid toxicity does not require RAGE protein. Biochem. Biophys. Res. Commun. 237: 37-40
19. 19 Kuner P., Schubenel R. and Hertel C. (1998) Beta-amyloid binds to p75NTR and activates NfkappaB in human neuroblastoma cells. J. Neurosci. Res. 54: 789-804
20. 20 Pillot T., Goethals M., Vanloo B., Talussot C., Brasseur R., Rosseneu M. et al. (1996) Fusogenic properties of the C-terminal domain of the Alzheimer β-amyloid peptide. J. Biol. Chem. 271: 13379-13382
21. 21 McLaurin J. and Chakrabartty A. (1996) Membrane disruption by Alzheimer β-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. J. Biol. Chem. 271: 26482-26489
22. 22 Muller W. E., Eckert G. P., Scheuer K., Cairns N. J., Maras A. and Gattaz W. F. (1998) Effects of beta-amyloid peptides on the fluidity of membranes from frontal and parietal lobes of human brain: high potencies of A-beta 1 43. J. Exp. Clin. Invest. 5: 10-15
23. 23 Keller J. N., Kindy M. S., Holtsberg F. W., St. Clair D. K., yen H.-C., Germeyer A. et al. (1998) Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J. Neurosci 18: 687-697
24. 24 Bruce-Keller A., Begley J. G., Fu W., Butterfield A. D., Bredesen D. E., Hutchins J. B. et al. (1998) Bcl-2 protects isolated plasma and mitochondrial membranes against lipid peroxidation induced by hydrogen peroxide and amyloid β-peptide. J. Neurochem. 70: 31-39
25. 25 Guo Q., Robinson N. and Mattson M. (1998) Secreted β-amyloid precursor protein counteracts the proapoptotic action of mutant presenilin-1 by activation of NF-κB and stabilization of calcium homeostasis. J. Biol. Chem. 273: 12341-12351
26. 26 Mattson M. P., Goodman Y., Luo H., Fu W. and Furukawa K. (1997) Activation of NF-κB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49: 681-697
27. 27 Akama K., Albanese C., Pestall R. G. and Van Eldik L. J. (1998) Amyloid β-peptide stimulates nitric oxide production in astrocytes through an NFκB-dependent mechanism. Proc. Natl. Acad. Sci. USA 95: 5795-5800
28. 28 Pike C.J., Ramezan-Arab N. and Cotman C. W. (1997) β-amyloid neurotoxicity in vitro: evidence of oxidative stress but not protection by antioxidants. J. Neurochem. 69: 1601-1611
29. 2+-dependent late phase. J. Neurochem. 67: 2074-2078
30. 2+ accumulation. J. Neurochem. 70: 1394-1400
31. 31 Behl C., Davis J. B., Klier G. F. and Schubert D. (1994) Amyloid β peptide induces necrosis rather than apoptosis. Brain Res. 645: 253-264
32. 32 Estus S., Tucker H. M., Rooyen C. van, Wright S., Brigham E., Wogulis M. et al. (1997) Aggregated amyloid-β protein induces cortical neuronal apoptosis and concomitant 'apoptotic' pattern of gene induction. J. Neurosci. 17: 7736-7745
33. 33 Paradis E., Douillard H., Koutroumanis M., Goodyer C. and LeBlanc A. (1996) Amyloid β peptide of Alzheimer's disease downregulates Bcl-2 and upregulates Bax expression in human neurons. J. Neurosci. 16: 7533-7539
34. 34 Monte S. M. de la, Sohn Y. K. and Wands J. R. (1997) Correlates of p53-and Fas (CD95)-mediated apoptosis in Alzheimer's disease. J. Neurol. Sci. 152: 73-83
35. 35 Neve R. L. and Robakis N. (1998) Alzheimer's disease: a re-examination of the amyloid hypothesis. Trends Neurosci. 21: 15-19
36. 36 Wujek J. R., Dority M. D., Frederickson R. C. A. and Brunden K. (1996) Deposits of Aβ fibrils are not toxic to cortical and hippocampal neurons in vitro. Neurobiol. Aging 17: 107-113
37. 37 Matter M. L., Zhang Z., Nordsedt C. and Ruolahti E. (1998) The α5β1 integrin mediates elimination of amyloid-β peptide and protects against apoptosis. J. Cell Biol. 141: 119-1030
38. 38 LaFerla F. M., Troncoso J. C., Strickland D. K., Kawas C. H. and Jay G. (1997) Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization. J. Clin. Invest. 100: 310-320
39. 39 Knauer M., Soreghan B., Burdick D., Kosmoki J. and Glabe C. (1992) Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4 β protein. Proc. Natl. Acad. Sci. USA 89: 7437-7441
40. 40 Tomita T., Tokuhiro S., Hashimoto T., Aiba K., Saido T. C., Maruyama K. et al. (1998) Molecular dissection of domains in mutant presenilin 2 that mediate overproduction of amyloidogenic forms of amyloid β peptides. J. Biol. Chem. 273: 21153-21160
41. 41 Takashima A., Muruyama M., Muruyama O., Khono T., Honda T., Yasutake K. et al. (1998) Presenilin 1 associates with glycogen synthase kinase-3β and its substrate tau. Proc. Natl. Acad. Sci. USA 95: 9637-9641
42. 42 Zhang W., Han S. W., McKeel D. W., Goate A. and Wu J. Y. (1998) Interaction of presenilins with the filamin family of actin-binding proteins. J. Neurosci. 18: 914-922
43. 43 Zhang Z., Hartmann H., Do V. M., Abramowski D., Sturchler-Pierrat C., Staufenbiel M. et al. (1998) Destabilization of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature 395: 698-702
44. 44 Smine A., Xu X., Nishiyama K., Katada T., Gambetti P., Yadav S. P. et al. (1998) Regulation of brain G-protein go by Alzheimer's disease gene presenilin-1. J. Biol. Chem. 273: 16281-16288
45. 45 Buxbaum J. D., Choi E.-K., Luo Y., Lilliehook C., Crowley A. C., Merriam D. E. et al. (1998) Calsenilin: a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment. Nat. Med. 4: 1177-1181
46. 46 Shinozaki K., Maruyama K., Kume H., Tomita T., Saido T., Iwatsubo T. et al. (1998) The presenilin 2 loop domain interacts with the mu-calpain C-terminal region. Int. J. Mol. Med. 1: 797-799
47. 47 Wolozin B., Alexander P. and Palacino J. (1998) Regulation of apoptosis by presenilin I. Neurobiol. Aging 19: S23-S27
48. 48 Vito P., Wolozin B., Ganjei J. K., Iwasaki K., Lacana E. and D'Adamio L. (1996) Requirement of the familial Alzheimer's disease gene PS2 for apoptosis. J. Biol. Chem. 271: 31025-31028
49. 49 Kim T.-W., Pettingell W. H., Jung Y.-K.., Kovacs D. and Tanzi R. E. (1997) Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science 277: 373-376
50. 50 Keller J. N., Guo Q., Holtsberg F. W., Bruce-Keller A. J. and Mattson M. P. (1998) Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1. J. Neurosci. 18: 4439-4450
51. 51 Guo Q., Fu W., Xie J., Luo H., Sells S. F., Geddes J. et al. (1998) Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease. Nat. Med. 4: 957-962
52. 52 Chui D. H., Shirotani K., Tanahashi H., Akiyama H., Ozawa K., Kunishi T. et al. (1998) Both N-terminal and C-terminal fragments of presenilin 1 colocalize with neurofibrillary tangles in neurons and dystrophic neurites of senile plaques in Alzheimer's disease. J. Neurosci. Res. 53: 99-106
53. 53 Xia W., Zhang J., Perez R., Koo E. H. and Selkoe D. J. (1997) Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimer disease. Proc. Natl. Acad. Sci. USA 94: 8208-8213
54. 54 Brownless J., Irving N.G., Brion J.P., Gibb B. J., Wagner U., Woodgett J. et al. (1997) Tau phosphorylation in transgenic mice expressing glycogen syntase kinase-3beta transgenes. Neuroreports 8: 3251-3255
55. 55 Canu N., Dus L., Barbato C., Ciotti M. T., Brancolini C., Rinaldi A. M. et al. (1988) Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J. Neurosci. 18: 7061-7074
56. 56 Michaelis M. L., Ranciat N., Chen Y., Betchel M., Ragan R., Hepperle M. et al. (1998) Protection against β-amyloid toxicity in primary neurons by paclitaxel (taxol). J. Neurochem. 70: 1623-1627
57. 57 Thinakaran G., Regard J. B., Bouton C. M., Harris C. L., Price D. L., Borchelt D. R. et al. (1998) Stable association of presenilin derivatives and absence of presenilin interactions with APP. Neurobiol. Dis. 4: 438-453
58. 58 Zhou J., Liyanage U., Medina M., Ho C., Simmons A., Lovett M. et al. (1997) Presenilin 1 interaction in the brain with a novel member of the armadillo family. Neuroreports 8: 2085-2090
59. 59 Paresce D., Chung H. and Maxfield F. R. (1997) Slow degradation of aggregates of the Alzheimer's disease amyloid β-protein by microglial cells. J. Biol. Chem. 272: 29390-29397
60. 60 Weldon P. T., Rogers S. D., Ghilardi J. R., Finke M. P., Cleary J. P., O'Hare E. et al. (1998) Fibrillar β-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J. Neurosci. 18: 2161-2173
61. 61 El Khoury J., Hickman S. E., Thomas C. A., Loike J. D. and Silverstein S. C. (1998) Microglia, scavenger receptors, and the pathogenesis of Alzheimer's disease. Neurobiol. Aging 19: S81-S84
62. 62 Vitek M. P., Snell J., Dawson H. and Colton C. A. (1997) Modulation of nitric oxide production in human macrophages by apolipoprotein-E and amyloid-beta peptide. Biochem. Biophys. Res. Commun. 240: 391-394
63. 63 Harr S. D., Uint L., Hollister R., Hyman B. and Mendez A. J. (1996) Brain expression of apolipoprotcins E, J, and A-I in Alzheimer's disease. J. Neurochem. 66: 2429-2435
64. 64 Dupont-Wallois L., Soulié C., Sergeant N., Wavrant-de Wrieze N., Chartier-Harlin M.-C., Delacourte A. et al. (1997) ApoE synthesis in human neuroblastoma cells. Neurobiol. Dis. 4: 256-364
65. 65 Nathan B. P., Bellosta S., Sanan D. A., Wiesgraber K. H., Mahley R. W. and Pitas R. E. (1994) Differential effects of apolipoproteins E3 and E4 on neuronal outgrowth in vitro. Science 264: 850-852
66. 66 DeMattos R. B., Curtiss L. K. and Williams D. L. (1998) A minimally lipidaled form of cell-derived apolipoprotein E exhibits isoform-specific stimulation of neurite outgrowth in the absence of exogenous lipids or lipoproteins. J. Biol. Chem. 273: 4206-4212
67. 67 Nathan B. P., Chang K.-C., Bellosta S., Brisch E., Ge N., Mahley R. W. et al. (1995) The inhibitory effect of apolioprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J. Biol. Chem. 270: 19791-19799
68. 68 Jordan J., Galindo M. F., Miller R. J., Reardon C. A., Getz G. S. and LaDu M. J. (1998) Isoform-specific effect of apolipoprotein E on cell survival and β-amyloid-induced toxicily in rat hippocampal pyramidal neuronal cultures. J. Neurosci. 18: 195-204
69. 69 St Clair R. W. and Beisigel U. (1997) What do all the apolipoprotein E receptors do? Curr. Opin. Lipidol. 8: 243-245
70. 70 Schneider W., Nimpf J. and Bujo H. (1997) Novel members of the low density lipoprotein receptor superfamily and their potential roles in lipid metabolism. Curr. Opin. Lipidol. 8: 315-319
71. 71 Stockinger W., Hengstsschlager-Ottnad E., Novak S., Matus A., Höttinger M., Bauer J. et al. (1998) The low density lipoprotein receptor gene family: differential expression of two alpha2-macroglobulin receptors in the brain. J. Biol. Chem. 273: 32213-32221
72. 72 Aizawa Y., Fukatsu R., Takamuru Y., Tsuzuki K., Chiba H., Kobayashi K. et al. (1997) Ammo-terminus truncated apolipoprotein E is the major species in amyloid deposits in Alzheimer's disease-affected brains: a possible role for apolipoprotein E in Alzheimer's disease. Brain Res. 768: 208-214
73. 73 Pillot T., Goethals M., Vanloo B., Lins L., Brasseur R., Vandekerchkhove J. et al. (1997) Specific modulation of the fusogenic properties of the Alzheimer (-amyloid peptide by apolipoprotein E isoforms. Eur. J. Biochem. 243: 650-659
74. 74 Beffert U. and Poirier J. (1998) ApoE associated with lipid has a reduced capacity to inhibit beta-amyloid fibril formation. Neuroreports 9: 3321-3323
75. 75 Williams K. R., Saunders A. M., Roses A. D. and Armati P. J. (1998) Uptake and internalization of exogenous apolipoprotein E3 by cultured human central nervous system neurons. Neurobiol. Dis. 5: 271-279
76. 76 Namba Y., Tomonaga M., Kawasaki H., Otomo E. and Ikeda K. (1991) Apolipoprotein E immunoreactivity in cerebral deposits and neurofibrillary tangles in Alzheimer's disease brain. Brain Res. 541: 163-166
77. 77 Wang X., Ciraolo G., Morris R. and Gruenstein E. (1997) Identification of a neuronal endocytic pathway activated by an apolipoprotein E (apoE) receptor binding peptide. Brain Res. 778: 6-15
78. 78 Suo Z., Humphrey J., Kundtz A., Sethi F., Placzek A., Crawford F. et al. (1998) Soluble Alzheimer's beta-amyloid constricts the cerebral vasculature in vivo. Neurosci. Lett. 257: 77-80
79. 79 Paris D., Town T., Parker T. A., Humphrey J. and Mullan M. (1998) Isoform-specific vasoconstriction induced by apolipoprotein e and modulation of this effect by Alzheimer's beta-amyloid peptide. Neurosci. Lett. 256: 73-76
80. 80 Permanne B., Perez C., Soto C., Frangione B. and Wisniewski T. (1997) Detection of apolipoprotein E/dimeric soluble amyloid ( complexes in Alzheimer's disease brain supernatants. Biochem. Biophys. Res. Commun. 240: 715-720
81. 81 Gutman C. A., Strittmatter W., Weisgraber K. H. and Matthew W. D. (1997) Apolipoprotein E binds to and potentiates the biological activity of ciliary neurotrophic factor. J. Neurosci. 17: 6114-6121
82. 82 Igbavboa U., Avdulov N. A., Chochina S. V. and Wood W. G. (1997) Transbilayer distribution of cholesterol is modified in brain synaptic plasma membranes of knockout mice deficient in the low-density lipoprotein receptor, apolipoprotein E, or both proteins. J. Neurochem. 69: 1661-1667
83. 83 Klunk W. E., Xu C.-J., McClure R. J., Panchalingam K., Stanley J. A. and Pettergrew J. W. (1997) Aggregation of β-amyloid peptide is promoted by membrane phospholipid metabolites elevated in Alzheimer's disease brain. J. Neurochem. 69: 266-272
84. 84 Müller W. E., Koch S., Eckert A., Hartmann H. and Scheuer K. (1995) β-amyloid peptide decreases membrane fluidity. Brain Res. 674: 133-136
85. 85 Bodovitz S. and Klein W. L. (1996) Cholesterol modulates β-secretase cleavage of amyloid precursor protein. J. Biol. Chem. 271: 4436-4440
86. 86 Simons M., Keller P., De Strooper B., Beyreuther K., Dotti C. G. and Simons K. (1998) Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. USA 95: 6460-6464
87. 87 Racchi M., Baetta R., Salvietti N., Ianna P., Franceschini G., Paoletti R. et al. (1997) Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. Biochem. J. 322: 893-898
88. 88 Liu Y., Peterson D. A. and Schubert D. (1998) Amyloid beta peptide alters intracellular vesicle trafficking and cholesterol homeostasis. Proc. Natl. Acad. Sci. USA 95: 13266-13271
89. 2-Macroglobulin associates with (-amyloid peptide and prevents fibril formation. Proc. Natl. Acad. Sci. USA 95: 3275-3280
90. 90 Qiu W. Q., Borth W., Ye Z., Haas C., Teplow D. B. and Selkow D. (1996) Degradation of amyloid β-protein by a serine protease-α2-macroglobulin complex. J. Biol. Chem. 271: 8443-8451
91. 91 Pericak-Vance M. A., Bass M. P., Yamaoka L. H., Gaskell P. C, Scott W. K., Terwedow H. A. et al. (1997) Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA 278: 1237-1241